PRECISION BIOSCIENCES INC Debt Instrument, Interest Rate, Effective Percentage
PRECISION BIOSCIENCES INC (DTIL) had Debt Instrument, Interest Rate, Effective Percentage of 9.99% as of 2024-06-30, per its 10-Q filed 2024-08-01.
Discontinued › Notes › Debt Instruments
us-gaap:DebtInstrumentInterestRateEffectivePercentage · last filed 2024-08-01
- 2024-06-30: Debt Instrument, Interest Rate, Effective Percentage 9.99%.
- 2024-03-31: Debt Instrument, Interest Rate, Effective Percentage 10.27%.
- 2023-12-31: Debt Instrument, Interest Rate, Effective Percentage 10.30%.
- 2023-09-30: Debt Instrument, Interest Rate, Effective Percentage 10.30%.
| Period end | Debt Instrument, Interest Rate, Effective Percentage |
|---|---|
| 2024-06-30 | 9.99% 10-Q · filed 2024-08-01 |
| 2024-03-31 | 10.27% 10-Q · filed 2024-05-13 |
| 2023-12-31 | 10.30% 10-K · filed 2024-03-27 |
| 2023-09-30 | 10.30% 10-Q · filed 2023-11-07 |
| 2023-06-30 | 10.00% 10-Q · filed 2023-08-04 |
| 2023-03-31 | 9.77% 10-Q · filed 2023-05-09 |
| 2022-12-31 | 9.27% 10-K · filed 2023-03-09 |
| 2022-09-30 | 8.00% 10-Q · filed 2022-11-08 |
| 2022-06-30 | 6.50% 10-Q · filed 2022-08-08 |
| 2022-03-31 | 7.03% 10-Q · filed 2022-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |